FDA approves new drug for gout
On Dec. 22, the U.S. Food and Drug Administration (FDA) approved Zurampic (lesinurad) to treat high levels of uric acid in the blood (hyperuricemia) associated with gout, when…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.
